These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 17982902

  • 1. Therapeutic drug monitoring of antidepressants--clinical aspects.
    Laux G, Baumann P, Hiemke C, TDM group of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie.
    J Neural Transm Suppl; 2007; (72):261-7. PubMed ID: 17982902
    [Abstract] [Full Text] [Related]

  • 2. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
    Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G, Arbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie.
    Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
    [Abstract] [Full Text] [Related]

  • 3. The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.
    Baumann P, Ulrich S, Eckermann G, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G, Hiemke C, Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsyhiatrie - Therapeutic Drug Monitoring group.
    Dialogues Clin Neurosci; 2005 Nov; 7(3):231-47. PubMed ID: 16156382
    [Abstract] [Full Text] [Related]

  • 4. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
    Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G.
    Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 22053351
    [Abstract] [Full Text] [Related]

  • 5. [Recommendations for therapeutic monitoring of antidepressants].
    Baumann P, Rougemont M, Corruble E, Hiemke C, Groupe AGNP-DPM.
    Rev Med Suisse; 2013 Mar 13; 9(377):577-86. PubMed ID: 23534245
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
    Baumann P, Hiemke C, Ulrich S, Eckermann G, Kuss HL, Laux G, Müller-Oerlingenhausen B, Rao ML, Riederer P, Zernig G, AGNP-TDM, Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) - Therapeutic Drug Monitoring (TDM).
    Rev Med Suisse; 2006 May 24; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ, Dragicevic A, Fric M, Gaertner I, Grasmäder K, Härtter S, Hermann E, Kuss HJ, Laux G, Oehl W, Rao ML, Rollmann N, Weigmann H, Weber-Labonte M, Hiemke C.
    Pharmacopsychiatry; 2003 May 24; 36(3):98-104. PubMed ID: 12806567
    [Abstract] [Full Text] [Related]

  • 8. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
    Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G.
    Pharmacopsychiatry; 2011 Sep 24; 44(6):195-235. PubMed ID: 21969060
    [Abstract] [Full Text] [Related]

  • 9. French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs.
    Rougemont M, Ulrich S, Hiemke C, Corruble E, Baumann P.
    Fundam Clin Pharmacol; 2010 Jun 24; 24(3):377-84. PubMed ID: 20199581
    [Abstract] [Full Text] [Related]

  • 10. Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring.
    Preskorn SH.
    J Clin Psychiatry; 1989 Jul 24; 50 Suppl():34-42; discussion 43-6. PubMed ID: 2661550
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic drug monitoring in depression.
    Radziwoń-Zaleska M, Matsumoto H, Skalski M, Androsiuk W, Dziklińska A, Kunicki PK.
    Pol J Pharmacol; 2000 Jul 24; 52(4):255-66. PubMed ID: 11345481
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness.
    Preskorn SH, Fast GA.
    J Clin Psychiatry; 1991 Jun 24; 52 Suppl():23-33. PubMed ID: 1904862
    [Abstract] [Full Text] [Related]

  • 13. TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>.
    Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, Gründer G, Haen E, Baumann P, Bergemann N, Clement HW, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud-Sirot E, Laux G, Messer T, Mössner R, Müller MJ, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zurek G, Hiemke C.
    World J Biol Psychiatry; 2018 Apr 24; 19(3):162-174. PubMed ID: 29493375
    [Abstract] [Full Text] [Related]

  • 14. Use of plasma level monitoring of antidepressants in clinical practice. Towards an analysis of clinical utility.
    Vuille F, Amey M, Baumann P.
    Pharmacopsychiatry; 1991 Nov 24; 24(6):190-5. PubMed ID: 1812496
    [Abstract] [Full Text] [Related]

  • 15. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
    Justesen US.
    Dan Med Bull; 2008 Nov 24; 55(4):165-85. PubMed ID: 19232158
    [Abstract] [Full Text] [Related]

  • 16. Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.
    Schoretsanitis G, Kane JM, Correll CU, Marder SR, Citrome L, Newcomer JW, Robinson DG, Goff DC, Kelly DL, Freudenreich O, Piacentino D, Paulzen M, Conca A, Zernig G, Haen E, Baumann P, Hiemke C, Gründer G, American Society of Clinical PsychopharmacologyMembers of the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie are listed at the end of the article., Pharmakopsychiatrie TTDMTFOTAFNU.
    J Clin Psychiatry; 2020 May 19; 81(3):. PubMed ID: 32433836
    [Abstract] [Full Text] [Related]

  • 17. [Paraclinical monitoring of antidepressant prescription].
    Sechter D, Vandel S, Bonin B.
    Encephale; 1995 Dec 19; 21 Spec No 4():39-41. PubMed ID: 8808345
    [No Abstract] [Full Text] [Related]

  • 18. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F, Eliasson E.
    Clin Pharmacol Ther; 2007 Jun 19; 81(6):899-902. PubMed ID: 17392719
    [Abstract] [Full Text] [Related]

  • 19. Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey.
    Waldschmitt C, Vogel F, Pfuhlmann B, Hiemke C.
    Pharmacopsychiatry; 2009 Sep 19; 42(5):189-93. PubMed ID: 19724981
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic monitoring of tricyclic antidepressant drugs].
    Grzesiak M, Beszłej JA, Szewczuk-Bogusławska M.
    Psychiatr Pol; 2003 Sep 19; 37(5):825-37. PubMed ID: 14631602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.